Gefitinib, Erlotinib or Afatinib for EGFR Mutated NSCLC...

Gefitinib, Erlotinib or Afatinib for EGFR Mutated NSCLC patients? A Meta-Analysis and Indirect Comparison on the Efficacy of First-Line Tyrosine Kinase Inhibitors

Holleman, MS, Zaim, R, Uyl-De Groot, CA
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.2105
Date:
November, 2016
File:
PDF, 60 KB
english, 2016
Conversion to is in progress
Conversion to is failed